We are live on
!
Find out more
ROTUOC
Regents of the University of California Portfolio holdings
AUM
$4.36B
1-Year Est. Return
33.89%
This Fund
S&P 500
This Quarter
Est. Return
-3.23%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$666M
AUM Growth
-$47.9M
(-6.7%)
Cap. Flow
+$998K
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
93.66%
Holding
44
New
4
Increased
2
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caribou Biosciences
CRBU
|
+$1.91M |
| 2 |
Airbnb
ABNB
|
+$1.35M |
| 3 |
Datadog
DDOG
|
+$460K |
| 4 |
California Water Service
CWT
|
+$220K |
| 5 |
TGNA
TEGNA Inc
TGNA
|
+$193K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sana Biotechnology
SANA
|
+$1.87M |
| 2 |
Arvinas
ARVN
|
+$1.29M |
| 3 |
CytomX Therapeutics
CTMX
|
+$162K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 72.82% |
| 2 | Consumer Discretionary | 9.4% |
| 3 | Technology | 7.69% |
| 4 | Healthcare | 5.05% |
| 5 | Real Estate | 1.59% |
Similar funds
SFM
EC
EQF
NEI
FIS
CAU
IUHSA
CW
Regents of the University of California's Q1 2022 Portfolio in Review
As of Q1 2022, Regents of the University of California held 44 positions worth $666M, down 6.7% from $714M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Regents of the University of California's Q1 2022 filing shows 4 new, 2 increased, 2 reduced and 1 closed positions. Its largest new stake was Caribou Biosciences: 181,304 shares worth $1.66M. The largest sale was Sana Biotechnology, an estimated $1.87M.
By sector, the portfolio is most concentrated in Financials at 73% of assets, up from 66% a quarter earlier, followed by Consumer Discretionary and Technology.
- Regents of the University of California's largest Q1 2022 buy was Caribou Biosciences: 181,304 shares worth $1.66M.
- Regents of the University of California added most to Airbnb in Q1 2022, an estimated $1.35M increase.
- Regents of the University of California's biggest Q1 2022 reduction was Sana Biotechnology, cutting an estimated $1.87M.
- Regents of the University of California fully exited CytomX Therapeutics in Q1 2022, selling an estimated $162K.
- Regents of the University of California's ten largest holdings make up 94% of its $666M portfolio in Q1 2022.
- Regents of the University of California opened 4 new positions and closed 1 in Q1 2022.
- Regents of the University of California's portfolio value fell 6.7% quarter-over-quarter to $666M.
Based on Regents of the University of California's 13F filing for Q1 2022, filed 25 Apr 2022.